Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Andrew J. Yee, MD is the Clinical Director of the Center for Multiple Myeloma at Massachusetts General Hospital, Mass General Brigham Cancer Institute, and Assistant Professor of Medicine at Harvard Medical School. He received his medical degree from Harvard Medical School, followed by training in internal medicine at Massachusetts General Hospital and hematology and oncology at Dana-Farber Cancer Institute/Partners Cancer Care. He sees patients with multiple myeloma and plasma cell dyscrasias. He is actively involved in clinical trials in multiple myeloma, where he leads several investigator-initiated trials and serves as principal investigator on a range of multicenter trials.

Dr. Misialek currently serves as Chair of Pathology at Newton-Wellesley Hospital, Newton, MA, part of the Mass General Brigham system. He is the Medical Director of chemistry, point-of-care testing, central processing and phlebotomy. He is a clinical assistant professor of pathology at Tufts University School of Medicine where he regularly instructs medical students and pathology residents. He is a Visiting Scientist at the Massachusetts Institute of Technology. He is the immediate past president of the Massachusetts Society of Pathologists. Dr. Misialek is a strong advocate for pathology and is very active in the College of American Pathologists, having served on numerous committees. His passion is to make widely known the value that pathologists bring to the health care team.